Nutraceutical Contract Manufacturing Services Global Market Report 2024

The nutraceutical contract manufacturing services market size has grown rapidly in recent years. It will grow from $154.67 billion in 2023 to $174.09 billion in 2024 at a compound annual growth rate (CAGR) of 12.6%. The growth observed in the historical period can be credited to several factors, including heightened consumer awareness regarding health, an increase in the adoption of preventive healthcare practices, adherence to regulatory standards, the rising demand from consumers for customized products, and the expansion of e-commerce platforms facilitating accessibility and sales.

The nutraceutical contract manufacturing services market size is expected to see rapid growth in the next few years. It will grow to $281.76 billion in 2028 at a compound annual growth rate (CAGR) of 12.8%. The anticipated growth in the forecasted period can be attributed to substantial investments in research and development, the presence of an aging population emphasizing healthy aging, an increasing demand for clean label products, and the ongoing digital transformation across industries. Key trends expected in this forecasted period include a heightened focus on enhancing immune health, the rising popularity of plant-based and vegan formulations, the emergence of CBD and hemp-derived products, the integration of e-commerce platforms, and the utilization of AI and data-driven approaches in product formulations.

The anticipated surge in chronic diseases is poised to be a key driver for the growth of the nutraceutical contract manufacturing services market. Chronic diseases, characterized by long-lasting effects lasting three months or more and often worsening over time, are on the rise. Nutraceutical contract manufacturing services play a vital role in offering nutraceutical brands accelerated product development and production timelines. This facilitates the creation of high-quality, customized nutraceutical products aimed at managing and preventing chronic diseases. As of January 2023, the National Center for Biotechnology Information (NCBI) reported a projection indicating a 99.5% increase in the number of individuals aged 50 years and older with one or more chronic illnesses, reaching 142.66 million by 2050, up from 71.522 million in 2020 in the United States. Additionally, a report from the National Council on Aging in April 2022 highlighted that approximately 80% of individuals aged 65 and older in the United States are expected to have at least one chronic ailment, with 68% having two or more. Consequently, the escalating prevalence of chronic diseases is anticipated to drive the growth of the nutraceutical contract manufacturing services market.

The escalating proportion of aging individuals is set to contribute significantly to the growth of the nutraceutical contract manufacturing services market. An aging population, characterized by a higher percentage or increasing number of elderly individuals within a specific population or society, is a demographic trend with far-reaching implications. Nutraceutical contract manufacturing services play a crucial role in enhancing the well-being of the aging population by providing tailored, high-quality, and convenient nutritional solutions that address specific age-related challenges and support overall health. As of June 2023, The United States Census Bureau reported that the country's median age increased by 0.2 years to 38.9 years in 2022, indicating a continual aging of the population. Consequently, the growing proportion of aging individuals stands out as a significant factor driving the growth of the nutraceutical contract manufacturing services market.

The nutraceutical contract manufacturing services market is witnessing a notable trend with increasing investments in the establishment of new manufacturing facilities. This trend is gaining popularity as companies recognize the importance of expanding their production capabilities to meet the growing demand for nutraceutical products. A case in point is Evonik Industries AG, a Germany-based specialty chemicals company providing nutraceutical contract manufacturing services. In March 2023, the company inaugurated a new Good Manufacturing Practice (GMP) facility dedicated to the production of lipids for advanced pharmaceutical drug delivery applications. Similarly, Star Combo Pharma, an Austria-based company in the nutraceutical contract manufacturing services sector, made a significant investment of $7.5 million in June 2022 to establish a new facility, aiming to double its manufacturing output.

Major players in the nutraceutical contract manufacturing services market are actively engaged in the development of innovative platforms to enhance their profitability and market standing. A nutraceutical contract manufacturing and development platform comprises a comprehensive set of services, resources, and capabilities provided by a company to assist clients in outsourcing the manufacturing and development of nutraceutical products. Illustratively, in November 2023, Lallemand Health Solutions, a Canada-based probiotics manufacturer, launched Expert'Biome CDMO. This cutting-edge contract manufacturing and development platform is designed to support partners in advancing next-generation strains. Offering services such as strain characterization, scale-up, drug synthesis, and other manufacturing steps, Expert'Biome ensures excellence in investigational and commercial biological product development. The manufacturing facilities adhere to the highest quality standards, including current Good Manufacturing Practice (cGMP) Pharma, and are supported by internationally recognized accreditations. This strategic approach underscores the commitment of major companies to excellence in nutraceutical contract manufacturing services.

In January 2023, Sirio Pharma, a China-based company specializing in the development and contract manufacturing of nutritional and dietary supplements, successfully acquired Best Formulations for an undisclosed sum. This strategic acquisition is intended to bolster Sirio Pharma's global footprint and reinforce its commitment to delivering top-notch products to a diverse clientele worldwide. By incorporating Best Formulations, a US-based contract manufacturer renowned for its expertise in nutritional supplements and personal care products, Sirio Pharma aims to cater to the production needs of both international and local brands, elevating its capacity to meet a wider spectrum of customer demands.

Major companies operating in the nutraceutical contract manufacturing services market report are Nutra Manufacturing Inc., Royal DSM, Lonza Group AG, Glanbia Plc., Herbalife International of America Inc., Catalent Inc., Ashland Global Holdings Inc., American Health Foundations Inc., Nutraceutical Corporation, Robinson Pharma Inc., Gemini Pharmaceuticals Inc., Nutrivo, Menadiona, NutraLab Canada Ltd., Martínez Nieto, Rain Nutrience Ltd., Biovencer Healthcare Pvt Ltd., NutraScience Labs, ABH Pharma Inc., NutraPak USA, Biotrex Nutraceuticals, Nutrafill LLC, Quest Nutra Pharma, EnzymeWorks Inc., Vestanutra.

Asia-Pacific was the largest region in the nutraceutical contract manufacturing services market in 2023. The regions covered in the nutraceutical contract manufacturing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the nutraceutical contract manufacturing services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The primary product categories within nutraceutical contract manufacturing services include dietary supplements, functional foods, and beverages. Dietary supplements encompass products containing vitamins, minerals, herbs, botanicals, amino acids, or other dietary constituents intended to supplement an individual's diet. These supplements are available in various forms such as tablets, capsules, liquid oral solutions, powder in sachets or jars, gummies, energy bars, and other formulations. These products cater to diverse end-users, including large pharmaceutical companies, small and medium-sized pharmaceutical firms, generic pharmaceutical companies, and others in the market.

The nutraceutical contract manufacturing services research report is one of a series of new reports that provides nutraceutical contract manufacturing services market statistics, including the nutraceutical contract manufacturing services industry's global market size, regional shares, competitors with a nutraceutical contract manufacturing services market share, detailed nutraceutical contract manufacturing services market segments, market trends, and opportunities, and any further data you may need to thrive in the nutraceutical contract manufacturing services industry. This nutraceutical contract manufacturing services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The nutraceutical contract manufacturing services market includes revenues earned by entities by providing formulation development, ingredient sourcing, screen printing and labeling, and quality control services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).


The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.